Top Markets
Coin of the day
Akums Drugs & Pharmaceuticals Ltd. Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd.

AKUMS
Kedudukan dalam Saham #8292
Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in... Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).
Harga Saham
$8.53
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.31B
Perubahan (1 hari)
1.50%
Perubahan (1 tahun)
65.49%
Negara
IN
Perdagangan Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Kategori

EPS untuk Akums Drugs & Pharmaceuticals Ltd. (AKUMS)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Akums Drugs & Pharmaceuticals Ltd., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Akums Drugs & Pharmaceuticals Ltd. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa